News summary

Longevity fund Immortal Dragons invests in stem cell startup Renewal Bio

Source: Longevity Technology • Published: 30 Sept 2026, 08:36

Summarized by Masters of Longevity from Longevity Technology.

A news piece about a longevity fund’s investment in a regenerative medicine startup, previewing an article on biotech financing and stem-cell platform development.

Longevity fund Immortal Dragons invests in stem cell startup Renewal Bio
Key Takeaways
  • Longevity fund Immortal Dragons invests in stem cell startup Renewal Bio Longevity.Technology is growing fast; we are open to conversations with prospective partners and investors who share our vision.
  • Immortal Dragons has made a strategic investment in Renewal Bio, an Israeli regenerative medicine company building a patient-matched cell platform.
Read the full article at Longevity Technology ↗

Continue exploring

Recommended MoL Picks

MoL PickMelatonin and Heart Failure: What the Evidence Actually ShowsA 2025 study linked melatonin use with heart failure. A 2026 analysis found no significant association. Their different designs explain why the question remains open.MoL PickCan Doctors Be Trained for the Longevity Era?A new global survey suggests that healthy longevity medicine education can change how physicians think and talk about ageing. But the evidence also highlights how much work remains before a rapidly growing field becomes routine clinical care.MoL PickWhat Changes in the Human Hippocampus with Age?A study of 40 postmortem brains maps a midlife shift in immune cells and a wider loss of cellular and genome organisation—but it does not show how to prevent cognitive decline.